Delivery Order SPE2DB25D7060-SPE2DB25FXSKV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,350.40 for Fluticasone Propionate HFA 220 MCG 12GM, a corticosteroid inhaler medication used for respiratory conditions. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.44 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 MCG 12GM, a corticosteroid inhaler medication. This competitive award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,451.00 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 44 MCG 10.6GM inhalers. This contract, which was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order executed without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $42,827.06 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.68 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with delivery performance required by August 6, 2025. This competitive award employs a firm fixed price model and represents a non-set-aside procurement executed on August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 44 mcg 10.6gm inhalers, valued at $1,257.22. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSKVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,307.57 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 MCG 10.6GM, a corticosteroid inhaler medication. The award, issued on April 30, 2025, with an ultimate completion date of May 1, 2025, was competitively awarded with no set-aside designation and employs firm fixed price terms. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's role as a critical distributor in the federal medical supply chain reflects its established capability to meet competitive federal procurement requirements across diverse therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/30/25 |